In the last 12 months, insiders at Chrome Holding Co. ($MEHCQ) filed 136 transactions with the SEC: 0 open-market purchases totaling $0 and 24 sales totaling $841,560. Net insider sentiment: net selling.
Chrome Holding Co. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- HIBBS KATHY L (Chief Administrative Officer) — 79 transactions totaling $1,330,935
- Chung Patrick S (Director) — 4 transactions totaling $134,999
- MONTGOMERY RICE VALERIE MD (Director) — 5 transactions totaling $130,000
- Selsavage Joseph Anthony (Interim CFO) — 10 transactions totaling $123,512
- BOTHA ROELOF (Director) — 4 transactions totaling $119,999
View all SEC Filings for Chrome Holding Co. (MEHCQ).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 20, 2025 | Selsavage Joseph Anthony | CEO, CFO & CAO | F | Class A Common Stock | 5232 | $3.70 | 86,163.0000 | 27,486,368 | 5.72% | 0.02% |
| June 9, 2025 | Wojcicki Anne | Director | C | Class A Common Stock, $0.0001 par value | 4931692 | $0.00 | 5,119,221.0000 | 25,817,117 | 2629.83% | 19.10% |
| June 9, 2025 | Wojcicki Anne | Director | C | Class B Common Stock, $0.0001 par value | 4931692 | $0.00 | 0.0000 | 25,817,117 | 100.00% | 19.10% |
| May 20, 2025 | Selsavage Joseph Anthony | Interim CEO, CFO & CAO | F | Class A Common Stock | 5073 | $3.36 | 91,395.0000 | 25,817,117 | 5.26% | 0.02% |
| Feb. 20, 2025 | Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | F | Class A Common Stock | 5654 | $2.74 | 96,468.0000 | 24,794,645 | 5.54% | 0.02% |
| Nov. 20, 2024 | Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | F | Class A Common Stock | 5279 | $3.15 | 102,122.0000 | 24,794,645 | 4.92% | 0.02% |
| Aug. 26, 2024 | SCHELLER RICHARD H | Director | A | Class A Common Stock | 658485 | $0.00 | 895,961.0000 | 24,794,645 | 277.28% | 2.66% |
| Aug. 26, 2024 | MONTGOMERY RICE VALERIE MD | Director | A | Class A Common Stock | 658485 | $0.00 | 1,013,366.0000 | 24,794,645 | 185.55% | 2.66% |
| Aug. 26, 2024 | MONTGOMERY RICE VALERIE MD | Director | A | Class A Common Stock | 194552 | $0.33 | 1,207,918.0000 | 24,794,645 | 19.20% | 0.78% |
| Aug. 26, 2024 | Mohan Neal | Director | A | Class A Common Stock | 658485 | $0.00 | 904,291.0000 | 24,794,645 | 267.89% | 2.66% |
| Aug. 26, 2024 | Chung Patrick S | Director | A | Class A Common Stock | 658485 | $0.00 | 959,906.0000 | 24,794,645 | 218.46% | 2.66% |
| Aug. 26, 2024 | Chung Patrick S | Director | A | Class A Common Stock | 202035 | $0.33 | 1,161,941.0000 | 24,794,645 | 21.05% | 0.81% |
| Aug. 26, 2024 | BOTHA ROELOF | Director | A | Class A Common Stock | 658485 | $0.00 | 1,142,011.0000 | 24,794,645 | 136.18% | 2.66% |
| Aug. 26, 2024 | BOTHA ROELOF | Director | A | Class A Common Stock | 179586 | $0.33 | 1,142,011.0000 | 24,794,645 | 18.66% | 0.72% |
| Aug. 26, 2024 | Taylor Peter J. | Director | A | Class A Common Stock | 658485 | $0.00 | 981,217.0000 | 24,794,645 | 204.03% | 2.66% |
| Aug. 26, 2024 | Hernandez Sandra R MD | Director | A | Class A Common Stock | 658485 | $0.00 | 1,053,549.0000 | 24,794,645 | 166.68% | 2.66% |
| Aug. 26, 2024 | Hernandez Sandra R MD | Director | A | Class A Common Stock | 149655 | $0.33 | 1,203,204.0000 | 24,794,645 | 14.20% | 0.60% |
| Aug. 20, 2024 | Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | F | Class A Common Stock | 110388 | $0.36 | 2,148,002.0000 | 24,794,645 | 4.89% | 0.45% |
| Aug. 20, 2024 | Richards William G | Head of Therapeutics Discovery | F | Class A Common Stock | 57365 | $0.36 | 573,069.0000 | 24,794,645 | 9.10% | 0.23% |
| June 30, 2024 | Taylor Peter J. | Director | A | Class A Common Stock | 57515 | $0.00 | 322,732.0000 | 23,799,114 | 21.69% | 0.24% |
| June 30, 2024 | MONTGOMERY RICE VALERIE MD | Director | A | Class A Common Stock | 15337 | $0.00 | 354,881.0000 | 23,799,114 | 4.52% | 0.06% |
| June 30, 2024 | Hernandez Sandra R MD | Director | A | Class A Common Stock | 57515 | $0.00 | 395,064.0000 | 23,799,114 | 17.04% | 0.24% |
| May 21, 2024 | Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | A | Class A Common Stock | 1000000 | $0.00 | 2,258,390.0000 | 23,799,114 | 79.47% | 4.20% |
| May 20, 2024 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 35282 | $0.55 | 1,217,033.0000 | 23,799,114 | 2.82% | 0.15% |
| May 20, 2024 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 36913 | $0.55 | 1,258,390.0000 | 23,799,114 | 2.85% | 0.16% |
| May 20, 2024 | Richards William G | Head of Therapeutics Discovery | F | Class A Common Stock | 16106 | $0.55 | 630,434.0000 | 23,799,114 | 2.49% | 0.07% |
| May 2, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38551 | $0.42 | 1,290,866.0000 | 23,799,114 | 3.08% | 0.16% |
| May 2, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38551 | $0.49 | 1,252,315.0000 | 23,799,114 | 2.99% | 0.16% |
| May 2, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38551 | $0.00 | 0.0000 | 23,799,114 | 100.00% | 0.16% |
| April 18, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,290,863.0000 | 23,799,114 | 3.08% | 0.16% |
| April 18, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.47 | 1,252,315.0000 | 23,799,114 | 2.99% | 0.16% |
| April 18, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 38,551.0000 | 23,799,114 | 50.00% | 0.16% |
| April 4, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,290,863.0000 | 23,799,114 | 3.08% | 0.16% |
| April 4, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.50 | 1,252,315.0000 | 23,799,114 | 2.99% | 0.16% |
| April 4, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 77,099.0000 | 23,799,114 | 33.33% | 0.16% |
| March 21, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,290,863.0000 | 22,575,219 | 3.08% | 0.17% |
| March 21, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.46 | 1,252,315.0000 | 22,575,219 | 2.99% | 0.17% |
| March 21, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 115,647.0000 | 22,575,219 | 25.00% | 0.17% |
| March 7, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,290,863.0000 | 22,575,219 | 3.08% | 0.17% |
| March 7, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.53 | 1,252,315.0000 | 22,575,219 | 2.99% | 0.17% |
| March 7, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 154,195.0000 | 22,575,219 | 20.00% | 0.17% |
| Feb. 22, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,278,375.0000 | 22,575,219 | 3.11% | 0.17% |
| Feb. 22, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.61 | 1,239,827.0000 | 22,575,219 | 3.02% | 0.17% |
| Feb. 22, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 192,743.0000 | 22,575,219 | 16.67% | 0.17% |
| Feb. 20, 2024 | Richards William G | Head of Therapeutics Discovery | F | Class A Common Stock | 18497 | $0.72 | 646,540.0000 | 22,575,219 | 2.78% | 0.08% |
| Feb. 20, 2024 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 42395 | $0.72 | 1,273,659.0000 | 22,575,219 | 3.22% | 0.19% |
| Feb. 20, 2024 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 40522 | $0.72 | 1,239,827.0000 | 22,575,219 | 3.16% | 0.18% |
| Feb. 15, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,318,897.0000 | 22,575,219 | 3.01% | 0.17% |
| Feb. 15, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.78 | 1,280,349.0000 | 22,575,219 | 2.92% | 0.17% |
| Feb. 15, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 231,291.0000 | 22,575,219 | 14.29% | 0.17% |
| Jan. 25, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,318,897.0000 | 22,575,219 | 3.01% | 0.17% |
| Jan. 25, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.73 | 1,280,349.0000 | 22,575,219 | 2.92% | 0.17% |
| Jan. 25, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 269,839.0000 | 22,575,219 | 12.50% | 0.17% |
| Jan. 11, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,318,897.0000 | 22,575,219 | 3.01% | 0.17% |
| Jan. 11, 2024 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.72 | 1,280,349.0000 | 22,575,219 | 2.92% | 0.17% |
| Jan. 11, 2024 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 308,387.0000 | 22,575,219 | 11.11% | 0.17% |
| Dec. 28, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,318,897.0000 | 22,575,219 | 3.01% | 0.17% |
| Dec. 28, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.93 | 1,280,349.0000 | 22,575,219 | 2.92% | 0.17% |
| Dec. 28, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 346,935.0000 | 22,575,219 | 10.00% | 0.17% |
| Dec. 14, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,318,897.0000 | 22,575,219 | 3.01% | 0.17% |
| Dec. 14, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.97 | 1,280,349.0000 | 22,575,219 | 2.92% | 0.17% |
| Dec. 14, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 385,483.0000 | 22,575,219 | 9.09% | 0.17% |
| Nov. 30, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,318,897.0000 | 22,575,219 | 3.01% | 0.17% |
| Nov. 30, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.88 | 1,280,349.0000 | 22,575,219 | 2.92% | 0.17% |
| Nov. 30, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 424,031.0000 | 22,575,219 | 8.33% | 0.17% |
| Nov. 20, 2023 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 4627 | $0.91 | 1,280,349.0000 | 22,575,219 | 0.36% | 0.02% |
| Nov. 20, 2023 | Richards William G | Head of Therapeutics Discovery | F | Class A common Stock | 5695 | $0.91 | 665,037.0000 | 22,575,219 | 0.85% | 0.03% |
| Nov. 20, 2023 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 6208 | $0.91 | 1,316,054.0000 | 22,575,219 | 0.47% | 0.03% |
| Nov. 16, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,323,524.0000 | 22,575,219 | 3.00% | 0.17% |
| Nov. 16, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.77 | 1,284,976.0000 | 22,575,219 | 2.91% | 0.17% |
| Nov. 16, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 462,579.0000 | 22,575,219 | 7.69% | 0.17% |
| Nov. 2, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,323,524.0000 | 22,575,219 | 3.00% | 0.17% |
| Nov. 2, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.87 | 1,284,976.0000 | 22,575,219 | 2.91% | 0.17% |
| Nov. 2, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 501,127.0000 | 22,575,219 | 7.14% | 0.17% |
| Oct. 19, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,323,524.0000 | 22,575,219 | 3.00% | 0.17% |
| Oct. 19, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.81 | 1,284,976.0000 | 22,575,219 | 2.91% | 0.17% |
| Oct. 19, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 598,475.0000 | 22,575,219 | 6.05% | 0.17% |
| Oct. 5, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,323,524.0000 | 22,575,219 | 3.00% | 0.17% |
| Oct. 5, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $0.84 | 1,284,976.0000 | 22,575,219 | 2.91% | 0.17% |
| Oct. 5, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 637,023.0000 | 22,575,219 | 5.71% | 0.17% |
| Sept. 21, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 38548 | $0.42 | 1,323,524.0000 | 22,575,219 | 3.00% | 0.17% |
| Sept. 21, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 38548 | $1.00 | 1,284,976.0000 | 22,575,219 | 2.91% | 0.17% |
| Sept. 21, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 38548 | $0.00 | 675,571.0000 | 22,575,219 | 5.40% | 0.17% |
| Sept. 15, 2023 | Wojcicki Anne | Chief Executive Officer | A | Stock Option (Right to Buy) | 9527115 | $0.00 | 9,527,115.0000 | 22,575,219 | 9999.99% | 42.20% |
| Sept. 15, 2023 | Selsavage Joseph Anthony | Interim CFO | A | Class A Common Stock | 1025992 | $0.00 | 1,322,262.0000 | 22,575,219 | 346.30% | 4.54% |
| Sept. 15, 2023 | Selsavage Joseph Anthony | Interim CFO | A | Stock Option (Right to Buy) | 496204 | $0.00 | 496,204.0000 | 22,575,219 | 9999.99% | 2.20% |
| Sept. 15, 2023 | Richards William G | Head of Therapeutics Discovery | A | Class A common Stock | 344050 | $0.00 | 555,091.0000 | 22,575,219 | 163.03% | 1.52% |
| Sept. 15, 2023 | Richards William G | Head of Therapeutics Discovery | A | Class A common Stock | 115641 | $0.00 | 670,732.0000 | 22,575,219 | 20.83% | 0.51% |
| Sept. 15, 2023 | Richards William G | Head of Therapeutics Discovery | A | Stock Option (Right to Buy) | 166394 | $0.00 | 166,394.0000 | 22,575,219 | 9999.99% | 0.74% |
| Sept. 15, 2023 | HIBBS KATHY L | Chief Administrative Officer | A | Class A Common Stock | 1025992 | $0.00 | 1,284,976.0000 | 22,575,219 | 396.16% | 4.54% |
| Sept. 15, 2023 | HIBBS KATHY L | Chief Administrative Officer | A | Stock Option (Right to Buy) | 496204 | $0.00 | 496,204.0000 | 22,575,219 | 9999.99% | 2.20% |
| Sept. 7, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 40894 | $0.42 | 299,880.0000 | 22,575,219 | 15.79% | 0.18% |
| Sept. 7, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 40894 | $1.06 | 258,984.0000 | 22,575,219 | 13.64% | 0.18% |
| Sept. 7, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 40896 | $0.00 | 714,119.0000 | 22,575,219 | 5.42% | 0.18% |
| Sept. 6, 2023 | Hernandez Sandra R MD | Director | A | Class A Common Stock | 148492 | $0.00 | 291,678.0000 | 22,575,219 | 103.71% | 0.66% |
| Sept. 6, 2023 | Hernandez Sandra R MD | Director | A | Class A Common Stock | 45871 | $1.09 | 337,549.0000 | 22,575,219 | 15.73% | 0.20% |
| Sept. 6, 2023 | SCHELLER RICHARD H | Director | A | Class A Common Stock | 165088 | $0.00 | 237,476.0000 | 22,575,219 | 228.06% | 0.73% |
| Sept. 6, 2023 | MONTGOMERY RICE VALERIE MD | Director | A | Class A Common Stock | 130862 | $0.00 | 279,911.0000 | 22,575,219 | 87.80% | 0.58% |
| Sept. 6, 2023 | MONTGOMERY RICE VALERIE MD | Director | A | Class A Common Stock | 59633 | $1.09 | 339,544.0000 | 22,575,219 | 21.30% | 0.26% |
| Sept. 6, 2023 | Mohan Neal | Director | A | Class A Common Stock | 154997 | $0.00 | 245,806.0000 | 22,575,219 | 170.68% | 0.69% |
| Sept. 6, 2023 | Chung Patrick S | Director | A | Class A Common Stock | 126461 | $0.00 | 239,495.0000 | 22,575,219 | 111.88% | 0.56% |
| Sept. 6, 2023 | Chung Patrick S | Director | A | Class A Common Stock | 61926 | $1.09 | 301,421.0000 | 22,575,219 | 25.86% | 0.27% |
| Sept. 6, 2023 | BOTHA ROELOF | Director | A | Class A Common Stock | 138334 | $0.00 | 248,895.0000 | 22,575,219 | 125.12% | 0.61% |
| Sept. 6, 2023 | BOTHA ROELOF | Director | A | Class A Common Stock | 55045 | $1.09 | 303,940.0000 | 22,575,219 | 22.12% | 0.24% |
| Sept. 6, 2023 | Taylor Peter J. | Director | A | Class A Common Stock | 137566 | $0.00 | 265,217.0000 | 22,575,219 | 107.77% | 0.61% |
| Sept. 5, 2023 | Richards William G | Head of Therapeutics Discovery | S | Class A common Stock | 2538 | $1.08 | 211,041.0000 | 22,575,219 | 1.19% | 0.01% |
| Aug. 24, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 40894 | $0.42 | 293,406.0000 | 22,575,219 | 16.19% | 0.18% |
| Aug. 24, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 40894 | $1.05 | 252,512.0000 | 22,575,219 | 13.94% | 0.18% |
| Aug. 24, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 40894 | $0.00 | 755,015.0000 | 22,575,219 | 5.14% | 0.18% |
| Aug. 20, 2023 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 4628 | $1.14 | 252,512.0000 | 22,575,219 | 1.80% | 0.02% |
| Aug. 20, 2023 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 6209 | $1.14 | 286,537.0000 | 22,575,219 | 2.12% | 0.03% |
| Aug. 20, 2023 | Richards William G | Head of Therapeutics Discovery | F | Class A common Stock | 8185 | $1.14 | 211,041.0000 | 22,575,219 | 3.73% | 0.04% |
| Aug. 15, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 40894 | $0.42 | 298,034.0000 | 22,575,219 | 15.90% | 0.18% |
| Aug. 15, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 40894 | $1.32 | 257,140.0000 | 22,575,219 | 13.72% | 0.18% |
| Aug. 15, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 40894 | $0.00 | 795,909.0000 | 22,575,219 | 4.89% | 0.18% |
| July 27, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 40894 | $0.42 | 298,034.0000 | 22,575,219 | 15.90% | 0.18% |
| July 27, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 40894 | $1.89 | 257,140.0000 | 22,575,219 | 13.72% | 0.18% |
| July 27, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 40894 | $0.00 | 836,803.0000 | 22,575,219 | 4.66% | 0.18% |
| July 13, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 40894 | $0.42 | 298,034.0000 | 22,575,219 | 15.90% | 0.18% |
| July 13, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 40894 | $1.82 | 257,140.0000 | 22,575,219 | 13.72% | 0.18% |
| July 13, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 40894 | $0.00 | 877,697.0000 | 22,575,219 | 4.45% | 0.18% |
| June 29, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Class A Common Stock | 40894 | $0.42 | 298,034.0000 | 22,575,219 | 15.90% | 0.18% |
| June 29, 2023 | HIBBS KATHY L | Chief Administrative Officer | S | Class A Common Stock | 40894 | $1.72 | 257,140.0000 | 22,575,219 | 13.72% | 0.18% |
| June 29, 2023 | HIBBS KATHY L | Chief Administrative Officer | M | Stock Option (Right to Buy) | 40894 | $0.00 | 918,591.0000 | 22,575,219 | 4.26% | 0.18% |
| June 5, 2023 | HIBBS KATHY L | Chief Administrative Officer | A | Class A Common Stock | 43659 | $0.00 | 272,238.0000 | 22,575,219 | 19.10% | 0.19% |
| June 5, 2023 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 15098 | $2.08 | 257,140.0000 | 22,575,219 | 5.55% | 0.07% |
| June 5, 2023 | Hillan Kenneth J. | Chief Therapeutics Officer | A | Class A Common Stock | 44381 | $0.00 | 237,223.0000 | 22,575,219 | 23.01% | 0.20% |
| June 5, 2023 | Hillan Kenneth J. | Chief Therapeutics Officer | F | Class A Common Stock | 15347 | $2.08 | 221,876.0000 | 22,575,219 | 6.47% | 0.07% |
| June 5, 2023 | Selsavage Joseph Anthony | Interim CFO | A | Class A Common Stock | 37808 | $0.00 | 305,821.0000 | 22,575,219 | 14.11% | 0.17% |
| June 5, 2023 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 13075 | $2.08 | 292,746.0000 | 22,575,219 | 4.28% | 0.06% |
| May 20, 2023 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 6209 | $1.94 | 268,013.0000 | 22,575,219 | 2.26% | 0.03% |
| May 20, 2023 | Hillan Kenneth J. | Chief Therapeutics Officer | F | Class A Common Stock | 4628 | $1.94 | 192,842.0000 | 22,575,219 | 2.34% | 0.02% |
| May 20, 2023 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 4628 | $1.94 | 228,579.0000 | 22,575,219 | 1.98% | 0.02% |
| Feb. 20, 2023 | Hillan Kenneth J. | Chief Therapeutics Officer | F | Class A Common Stock | 5457 | $2.87 | 191,705.0000 | 0 | 2.77% | 0.00% |
| Feb. 20, 2023 | Selsavage Joseph Anthony | Interim CFO | F | Class A Common Stock | 7321 | $2.87 | 269,957.0000 | 0 | 2.64% | 0.00% |
| Feb. 20, 2023 | HIBBS KATHY L | Chief Administrative Officer | F | Class A Common Stock | 5457 | $2.87 | 230,372.0000 | 0 | 2.31% | 0.00% |